| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Repligen Corporation (RGEN) has 15 insiders with recent SEC Form 4 filings, including 5 buys and 15 sells. RGEN is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 99.0K | $12.36M | - | |
| Dir | 91.8K | $11.46M | - | |
| CEO | 54.2K | $6.77M | -3,832 | |
| Other | 8.5K | $1.07M | - | |
| CFO | 8.3K | $1.04M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | Pax Margaret | Director | Buy | 250 | $150.69 | $37,672.50 | +31.5% | -17.5% | -21.9% | |
| Nov 21, 2024 | Hunt Anthony75 | Director | Sale+OE | 24,246 | $139.67 | $3,386,438.82 | -14.8% | +6.3% | +14.6% | |
| Sep 10, 2024 | Hunt Anthony75 | Director | Sale+OE | 22,191 | $145.37 | $3,225,927.40 | -3.6% | +5.5% | -18.0% | |
| Aug 2, 2024 | Kuriyel Ralf72 | Senior VP, R&D | Sale+OE | 7,148 | $159.35 | $1,139,016.03 | -22.5% | -16.9% | -26.4% | |
| Aug 1, 2024 | Kuriyel Ralf72 | Senior VP, R&D | Sell | 4,465 | $165.67 | $739,716.55 | -18.8% | -17.7% | -28.2% | |
| Jun 14, 2024 | Madaus Martin D72 | Director | Buy | 1,615 | $124.94 | $201,776.10 | +23.4% | +13.0% | +1.5% | |
| Jun 14, 2024 | Hunt Anthony75 | Chief Executive Officer | Buy | 2,000 | $124.08 | $248,160.00 | +1.2% | +13.0% | +1.5% | |
| Jun 14, 2024 | Barthelemy Nicolas67 | Director | Buy | 1,200 | $125.45 | $150,540.00 | +34.6% | +13.0% | +1.5% | |
| May 21, 2024 | Hunt Anthony75 | Chief Executive Officer | Sell | 20,072 | $168.26 | $3,377,283.01 | -1.9% | -7.8% | -28.0% | |
| Mar 11, 2024 | Kuriyel Ralf72 | Senior VP, R&D | Sale+OE | 3,517 | $193.73 | $681,348.41 | -12.7% | -26.9% | -23.8% |